A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management

References

• Tarasova VD, Tuttle RM. A Risk-adapted approach to follow-up in differentiated thyroid cancer. Rambam Maimonides Med J. 2016;7(1):RMMJ.10231.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: thyroid carcinoma version1.2018. [cited 2018 Jan15]. Available from: https://www.nccn.org/.
   Google Scholar
• Brito JP, Ito Y, Miyauchi A, et al. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid. 2016;26(1):144-149.
   Web of Science ®Google Scholar
• Groopman J, Hartzband P. Your medical mind. How to decide what is right for you. New York: Penguin Books; 2011. p. 308.
   Google Scholar
• Scherer LD, Caverly TJ, Burke J, et al. Development of the medical maximizer-minimizer scale. Health Psychol. 2016;35:1276–1287. Epub 2016 Sep 12.
   PubMed Web of Science ®Google Scholar
• D’Agostino TA, Shuk E, Maloney E, et al. Treatment decision making in early-stage papillary thyroid cancer. Psychooncology. 2018;27(1):61-68.
   Google Scholar
• Tuttle RM, Fagin JA, Minkowitz G, et al. Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg. 2017;143:1015–1020.
   PubMed Web of Science ®Google Scholar
• Miyauchi A, Kudo T, Ito Y, et al. Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance. Surgery. 2018;163:48–52. Epub 2017 Nov 2.
   PubMed Web of Science ®Google Scholar
• Rodrigues AC, Penna G, Rodrigues E, et al. The genetics of papillary microcarcinomas of the thyroid: diagnostic and prognostic implications. Curr Genomics. 2017;18:244–254.
   PubMed Web of Science ®Google Scholar
• Nikiforov YE. Role of molecular markers in thyroid nodule management: then and now. Endocr Pract. 2017;23: 979–988. Epub 2017 May 23.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Oda H. Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials. Eur J Surg Oncol. 2017;16: 30370-0.
   Google Scholar
• Kwon H, Oh HS, Kim M, et al. Active surveillance for patients with papillary thyroid microcarcinoma: a single center’s experience in Korea. J Clin Endocrinol Metab. 2017;102:1917–1925.
   PubMed Web of Science ®Google Scholar
• Miyauchi A, Ito Y, Oda H. Insights into the management of papillary microcarcinoma of the thyroid. Thyroid. 2018;28(1):23-31.
   Web of Science ®Google Scholar
• Nixon IJ, Palmer FL, Whitcher MM, et al. Thyroid isthmusectomy for well-differentiated thyroid cancer. Ann Surg Oncol. 2011;18:767–770. Epub 2010 Sep 30.
   PubMed Web of Science ®Google Scholar
• Conzo G, Avenia NAnsaldo GL, et al. Surgical treatment of thyroid follicular neoplasms: results of a retrospective analysis of a large clinical series. Endocrine. 2017;55:530-538. doi:10.1007/s12020-016-0953-2.
   PubMed Web of Science ®Google Scholar
• Gambardella C, Tartaglia ENunziata A, et al. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients. World J Surg Oncol. 2016;14:247. doi:10.1186/s12957-016-1003-5.
   PubMed Web of Science ®Google Scholar
• Kandil E, Gilson MMAlabbas HH, et al. Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer. Ann Surg Oncol. 2011;18:1028-1034.
   PubMed Web of Science ®Google Scholar
• Nixon IJ, Ganly I, Patel SG, et al. Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery. 2012;151:571–579.
   PubMed Web of Science ®Google Scholar
• Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237:399–407.
   PubMed Web of Science ®Google Scholar
• Momesso DP, Tuttle RM. Update on differentiated thyroid cancer staging. Endocrinol Metab Clin North Am. 2014;43:401–421.
   PubMed Web of Science ®Google Scholar
• Momesso DP, Vaisman F, Yang SP, et al. Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine. J Clin Endocrinol Metab. 2016;101:2692–2700.
   PubMed Web of Science ®Google Scholar
• Vaisman F, Momesso D, Bulzico DA, et al. Thyroid lobectomy is associated with excellent clinical outcomes in properly selected differentiated thyroid cancer patients with primary tumors greater than 1 cm. J Thyroid Res. 2013;2013:398194.
   PubMedGoogle Scholar
• Perrier ND, Brierley JD, Tuttle RM. Differentiated and anaplastic thyroid carcinoma: major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;1:21439.
   Google Scholar
• Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for differentiated and anaplastic thyroid cancer (Eighth Edition): what changed and why? Thyroid. 2017;27:751–756. Epub 2017 May 19.
   PubMed Web of Science ®Google Scholar
• Kluijfhout WP, Pasternak JD, Drake FT, et al. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine. Surgery. 2017;161:127–133. Epub 2016 Nov 14.
   PubMed Web of Science ®Google Scholar
• Calcatera NA, Lutfi W, Suman P, et al. Concordance of preoperative clinical stage with pathological stage in patients >/= 45 years with well-differentiated thyroid cancer. Endocr Pract. 2017;16:2017–2095.
   Google Scholar
• Duh QY, Shen WT. Clinical implications of postoperative up-staging of differentiated thyroid cancer based upon pathologic evaluation. Endocr Pract. 2017;16:2017–2179.
   Google Scholar